FY2023 NIH awards · Principal investigators
Radiology at Ohio State University
Columbus, OH
Funding
$6.8M
$6,753,295
Awards
17
FY2023 NIH awards in Radiology
Principal investigators
12
12 lead a grant here, 0 co-investigators
- NIH names only the principal investigators on an award, so this page lists only them. The department is the award's: it is where ScienceDex counts the award, not a list of the department's members.
- These are the awards in the Radiology row of the Ohio State University page.
Leads a grant in this department
12 contact PIs of these awards, by the funding they lead. Other principal investigators on an award are listed with it and under Co-investigators.
Denko, Nicholas C.
Leads 3 awards · $1,410,968
- 5R01CA262388-03Department: NIH department codeOvercoming Hypoxic Resistance in Non-Small Cell Lung Cancer By Targeting Mitochondrial Metabolism$627,890award amount
- 5R01CA255334-03Department: NIH department codeOvercoming hypoxic resistance to anti-cancer therapy$571,062award amount
- 3R01CA262388-03S1Department: NIH department codeOvercoming Hypoxic Resistance in Non-Small Cell Lung Cancer By Targeting Mitochondrial Metabolism$212,016award amount
Guo, Deliang
Leads 3 awards · $1,350,136
- 2R01NS104332-06Department: NIH department codeDetermining the role of lipid droplets and their therapeutic potential in glioblastoma$558,620award amount
- 5R01CA240726-04Department: NIH department codeDelineating how retinoic acids regulate lipid metabolism in glioblastoma and their resistance mechanisms$432,023award amount
- 5R01NS112935-04Department: NIH department codeIdentifying SREBP-1 activation mechanism in glioblastoma and its new role in regulating glutamine metabolism$359,493award amount
Mack, Stephen C
Leads 1 award · $720,877
- 1R01CA280203-01Department: NIH department codeRole of FACT in ZFTA-RelA fusion driven ependymoma$720,877award amount
Zhang, Junran
Leads 2 awards · $579,398
- 5R01CA249198-03Department: NIH department codeTargeting cholesterol metabolism and replication stress response in cancer therapy$349,713award amount
- 5R01CA240374-04Department: NIH department codeB55 alpha deficiency as a therapeutic target in cancer$229,685award amount
Pandharipande, Pari Vijay
Leads 1 award · $532,652
- 5R01CA266402-02Department: NIH department codeImproving Treatment Selection in Advanced Ovarian Cancer$532,652award amount
Sizemore, Gina Marie
Leads 1 award · $487,490
- 1R37CA282660-01Department: NIH department codePDGF-BB and the metastatic brain microenvironment$487,490award amount
Pitter, Kenneth L
Leads 1 award · $393,750
- 5DP5OD031864-03Department: NIH department codeCellular phenotypic heterogeneity and resistance to radiotherapy in pancreatic adenocarcinoma$393,750award amount
Zheng, Qingfei
Leads 1 award · $384,365
- 1R35GM150676-01Department: NIH department codeDevelopment of a Chemical Biology Toolbox to Investigate Histone Monoaminylation$384,365award amount
Wang, Qien
Leads 1 award · $339,618
- 5R01CA248027-03Department: NIH department codeRole of ALDH in PARP inhibitor resistance in HR-deficient ovarian cancer$339,618award amount
Chakravarti, Arnab
Leads 1 award · $294,894
- 5R01CA227874-05Department: NIH department codeDefining the molecular mechanisms regulating the hexosamine-N-glycosylation pathway in glioblastoma$294,894award amount
Papandreou, Ioanna
Leads 1 award · $180,397
- 5R21CA274046-02Department: NIH department codeMetabolic modulation of alkylating agent efficacy in MEK inhibitor resistant thyroid cancers.$180,397award amount
Benej, Martin
Leads 1 award · $78,750
- 1R03CA280489-01Department: NIH department codeValidation of OXPHOS gene amplification as a driver of hypoxia and treatment resistance in NSCLC$78,750award amount